CHDM clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
DMCRN-02-001: Assessing Pediatric Endpoints in DM1
Sorry, not currently recruiting here
The overall goal of the study is to establish valid clinical endpoint assessments for children with congenital myotonic dystrophy type 1 and childhood myotonic dystrophy type 1, and develop biomarkers for the condition.
Our lead scientists for CHDM research studies include Perry Shieh, MD, PhD.